Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Inhaler Stories

2014-02-25 08:32:43

ALBANY, New York, February 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pulmonary Drug Delivery Systems Market(Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global pulmonary drug delivery systems market was valued at USD 21.03billion in 2012 and is expected to grow...

2014-02-19 16:25:14

VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization. On Feb. 25, FDA's Nonprescription Drugs Advisory Committee and Pulmonary Allergy Drugs Committee will host a joint meeting to consider a new...

2014-02-14 12:24:25

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/477x2k/drug) have announced the addition of the "Drug Self-administration Markets to 2020" [http://www.researchandmarkets.com/research/477x2k/drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Therapeutic Indications, Product Strategies, Markets and Forecasts While alternative methods for delivering...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2014-01-02 23:22:46

Transparency Market Research Report added "Drug Device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse full report with TOC: http://www.transparencymarketresearch.com/drug-device-combination.html. Albany, New York, USA (PRWEB) January 02, 2014 According to a new market report published by Transparency Market Research "Drug Device Combination Products Market (Drug Eluting Stents, Infusion...

2013-12-24 08:23:21

NEW YORK, December 24, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global drug device combination...

2013-12-18 12:25:25

Vaporizer Technology Used in E-cigarettes Could Allow New, Easy Delivery Method for Pharmaceuticals, and Offer New Hope for Asthmatics, Migraines, Cystic Fibrosis, Diabetics and Many More. LOS ANGELES, Dec. 18, 2013 /PRNewswire/ -- Alsa Refinish LLC, a California-based company, has process and utility patent applications in place for a revolutionary medication delivery method. If successful, Alsa will hold patents for a device that delivers medications and herbal preparations...

2013-12-05 12:22:48

LISBON, Portugal, December 5, 2013 /PRNewswire/ -- Hovione announced today the expansion of its inhalation drug product development services with the introduction of a high precision MG2 FlexaLAB capsule filling machine. This investment is in response to market demand for high-precision, capsule filling services for inhaled products and is the last step in Hovione's plan to offer development services in all quadrants of inhalation projects: from API to formulation to...

2013-11-19 23:32:03

Achieve is conducting a safety and efficacy study on a new combination asthma treatment versus an inhaled treatment for adolescents and adult patients with asthma. Birmingham, Alabama (PRWEB) November 19, 2013 *To see if you qualify for this Asthma Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for...

2013-11-19 12:30:07

Company Takes First Major Step toward Becoming Fully Reporting CARSON CITY, Nev., Nov. 19, 2013 /PRNewswire/ -- Rapid Fire Marketing (Pink Sheets: RFMK), announced today that the Company has filed their Form 10 with the U.S. Securities and Exchange Commission (SEC) this morning. The filing of the Form 10 represents the first significant step in Rapid Fire Marketing's quest to become a fully reporting Company with the SEC. Subsequent to the Form 10 filing, the 10K will be filed...